New

Genomics Personalized Health Market

2021

Genomics Personalized Health Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Technology (NGS platforms, RT-PCR, Microarray, Genetic Analyzers); Test Type (Oncology Testing, Infectious Disease Testing, Orphan Disease Testing, Autoimmune Disease Testing, Obstetrics Testing, Others); End User (Academics and Research Institutes, Diagnostic Centers, Others) and Geography

| Report Code: TIPRE00007153 | No. of Pages: 150 | Category: Biotechnology | Status: Upcoming

Market Insights

Genomics Personalized Health Market 2028 By Technology, Test Type, End User and Geography | The Insight Partners

Covid
Assesing the covid-19 impact?
Get the Latest COVID-19 Analysis on this market
Request Now
Happy to join you in your fight against the COVID-19 economic pandemic!
MARKET OVERVIEW

Genomic personalized medicine and surgery is a novel approach to health care that tailors a patient's medical treatment to their genetic makeup. The enhanced approach is the consequence of better understanding of the human genome and strategies for using that information by physicians in medical and surgical management of their patients. These can be used to further identify a variety of complicated disorders and lead to the identification of more specialised treatments based on genomic profiling, removing some conventional medications that may be ineffective or have adverse side effects in specific patient populations.

MARKET SCOPE

The "Global Genomics Personalized Health Market Analysis to 2028" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of the genomics personalized health market with detailed market segmentation by technology, test type and end user. The report provides key statistics on the market status of the leading genomics personalized health market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION

  •   Based on technology the market is segmented as, NGS platforms, RT-PCR, microarray, genetic analyzers.
  •   Based on test type the market is segmented as, oncology testing, infectious disease testing, orphan disease testing, autoimmune disease testing, obstetrics testing, others.
  •   Based on end user the market is segmented as, academics & research institutes, diagnostic centers, others.

MARKET DYNAMICS
Drivers:

  •   Growing prevalence of chronic diseases such as cancer is the key driving factor for the market growth.
  •   Technological advancements in biopharmaceutical and biotechnology industries.
  •   Growing emphasis on genomic based research and growing funding for the same.

Restraints:

  •   However, presence of complex regulatory framework is likely to hamper market growth during the forecast period.



Get more information on this report :

REGIONAL FRAMEWORK


The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides an overview and forecast of the global market based on various segments. It also provides market size and forecast estimates from the year 2019 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), the Middle East and Africa (MEA), and South America. The genomics personalized health market by each region is later sub-segmented by respective countries and segments. The report covers the analysis and forecast of 18 countries globally along with the current trend and opportunities prevailing in the region.

The report analyzes factors affecting the market from both demand and supply side and further evaluates market dynamics affecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA, and South America after evaluating political, economic, social and technological factors affecting the genomics personalized health market in these regions.

IMPACT OF COVID-19 ON GENOMICS PERSONALIZED HEALTH MARKET

COVID-19 first began in Wuhan (China) during December 2019 and since then it has spread at a fast pace across the globe. The US, India, Brazil, Russia, France, the UK, Turkey, Italy, and Spain are some of the worst affected countries in terms confirmed cases and reported deaths. The COVID-19 has been affecting economies and industries in various countries due to lockdowns, travel bans, and business shutdowns. Shutdown of various plants and factories has affected the global supply chains and negatively impacted the manufacturing, delivery schedules, and sales of products in global market. Few companies have already announced possible delays in product deliveries and slump in future sales of their products. According to the current market situation, the report further assesses the present and future effects of the COVID-19 pandemic on the overall market, giving more reliable and authentic projections In addition to this, the global travel bans imposed by countries in Europe, Asia-Pacific, and North America are affecting the business collaborations and partnerships opportunities.



Get more information on this report :

MARKET PLAYERS


The report covers key developments in the genomics personalized health market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the marketwere acquisitions, and partnership & collaborations. These activities have paved way for the expansion of business and customer base of market players. The market payers from genomics personalized health market are anticipated to lucrative growth opportunities in the future with the rising demand for genomics personalized health in the global market.

The report also includes the profiles of key companies along with their SWOT analysis and market strategies in the genomics personalized health market. In addition, the report focuses on leading industry players with information such as company profiles, components, and services offered, financial information of the last 3 years, the key development in the past five years.

  •   QIAGEN
  •   Illumina, Inc.
  •   Thermo Fisher Scientific, Inc.
  •   Bio-Rad Laboratories, Inc.
  •   F. Hoffmann-La Roche Ltd
  •   Invitae Corporation
  •   Genetic Technologies Limited
  •   Lonza
  •   Interleukin Genetics, Inc
  •   DNAGenotek
The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.


Get more information on this report :

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Genomics Personalized Health Market - By Technology
1.3.2 Genomics Personalized Health Market - By Test Type
1.3.3 Genomics Personalized Health Market - By End User
1.3.4 Genomics Personalized Health Market - By Region
1.3.4.1 By Country

2. KEY TAKEAWAYS

3. RESEARCH METHODOLOGY

4. GENOMICS PERSONALIZED HEALTH MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PORTER'S FIVE FORCES ANALYSIS
4.2.1 Bargaining Power of Buyers
4.2.1 Bargaining Power of Suppliers
4.2.1 Threat of Substitute
4.2.1 Threat of New Entrants
4.2.1 Competitive Rivalry
4.3. EXPERT OPINIONS

5. GENOMICS PERSONALIZED HEALTH MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS

6. GENOMICS PERSONALIZED HEALTH MARKET - GLOBAL MARKET ANALYSIS
6.1. GENOMICS PERSONALIZED HEALTH - GLOBAL MARKET OVERVIEW
6.2. GENOMICS PERSONALIZED HEALTH - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING/MARKET SHARE

7. GENOMICS PERSONALIZED HEALTH MARKET - REVENUE AND FORECASTS TO 2028 - TECHNOLOGY
7.1. OVERVIEW
7.2. TECHNOLOGY MARKET FORECASTS AND ANALYSIS
7.3. NGS PLATFORMS
7.3.1. Overview
7.3.2. NGS platforms Market Forecast and Analysis
7.4. RT-PCR
7.4.1. Overview
7.4.2. RT-PCR Market Forecast and Analysis
7.5. MICROARRAY
7.5.1. Overview
7.5.2. Microarray Market Forecast and Analysis
7.6. GENETIC ANALYZERS
7.6.1. Overview
7.6.2. Genetic Analyzers Market Forecast and Analysis
8. GENOMICS PERSONALIZED HEALTH MARKET - REVENUE AND FORECASTS TO 2028 - TEST TYPE
8.1. OVERVIEW
8.2. TEST TYPE MARKET FORECASTS AND ANALYSIS
8.3. ONCOLOGY TESTING
8.3.1. Overview
8.3.2. Oncology Testing Market Forecast and Analysis
8.4. INFECTIOUS DISEASE TESTING
8.4.1. Overview
8.4.2. Infectious Disease Testing Market Forecast and Analysis
8.5. ORPHAN DISEASE TESTING
8.5.1. Overview
8.5.2. Orphan Disease Testing Market Forecast and Analysis
8.6. AUTOIMMUNE DISEASE TESTING
8.6.1. Overview
8.6.2. Autoimmune Disease Testing Market Forecast and Analysis
8.7. OBSTETRICS TESTING
8.7.1. Overview
8.7.2. Obstetrics Testing Market Forecast and Analysis
8.8. OTHERS
8.8.1. Overview
8.8.2. Others Market Forecast and Analysis
9. GENOMICS PERSONALIZED HEALTH MARKET - REVENUE AND FORECASTS TO 2028 - END USER
9.1. OVERVIEW
9.2. END USER MARKET FORECASTS AND ANALYSIS
9.3. ACADEMICS AND RESEARCH INSTITUTES
9.3.1. Overview
9.3.2. Academics and Research Institutes Market Forecast and Analysis
9.4. DIAGNOSTIC CENTERS
9.4.1. Overview
9.4.2. Diagnostic Centers Market Forecast and Analysis
9.5. OTHERS
9.5.1. Overview
9.5.2. Others Market Forecast and Analysis

10. GENOMICS PERSONALIZED HEALTH MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
10.1. NORTH AMERICA
10.1.1 North America Genomics Personalized Health Market Overview
10.1.2 North America Genomics Personalized Health Market Forecasts and Analysis
10.1.3 North America Genomics Personalized Health Market Forecasts and Analysis - By Technology
10.1.4 North America Genomics Personalized Health Market Forecasts and Analysis - By Test Type
10.1.5 North America Genomics Personalized Health Market Forecasts and Analysis - By End User
10.1.6 North America Genomics Personalized Health Market Forecasts and Analysis - By Countries
10.1.6.1 United States Genomics Personalized Health Market
10.1.6.1.1 United States Genomics Personalized Health Market by Technology
10.1.6.1.2 United States Genomics Personalized Health Market by Test Type
10.1.6.1.3 United States Genomics Personalized Health Market by End User
10.1.6.2 Canada Genomics Personalized Health Market
10.1.6.2.1 Canada Genomics Personalized Health Market by Technology
10.1.6.2.2 Canada Genomics Personalized Health Market by Test Type
10.1.6.2.3 Canada Genomics Personalized Health Market by End User
10.1.6.3 Mexico Genomics Personalized Health Market
10.1.6.3.1 Mexico Genomics Personalized Health Market by Technology
10.1.6.3.2 Mexico Genomics Personalized Health Market by Test Type
10.1.6.3.3 Mexico Genomics Personalized Health Market by End User
10.2. EUROPE
10.2.1 Europe Genomics Personalized Health Market Overview
10.2.2 Europe Genomics Personalized Health Market Forecasts and Analysis
10.2.3 Europe Genomics Personalized Health Market Forecasts and Analysis - By Technology
10.2.4 Europe Genomics Personalized Health Market Forecasts and Analysis - By Test Type
10.2.5 Europe Genomics Personalized Health Market Forecasts and Analysis - By End User
10.2.6 Europe Genomics Personalized Health Market Forecasts and Analysis - By Countries
10.2.6.1 Germany Genomics Personalized Health Market
10.2.6.1.1 Germany Genomics Personalized Health Market by Technology
10.2.6.1.2 Germany Genomics Personalized Health Market by Test Type
10.2.6.1.3 Germany Genomics Personalized Health Market by End User
10.2.6.2 France Genomics Personalized Health Market
10.2.6.2.1 France Genomics Personalized Health Market by Technology
10.2.6.2.2 France Genomics Personalized Health Market by Test Type
10.2.6.2.3 France Genomics Personalized Health Market by End User
10.2.6.3 Italy Genomics Personalized Health Market
10.2.6.3.1 Italy Genomics Personalized Health Market by Technology
10.2.6.3.2 Italy Genomics Personalized Health Market by Test Type
10.2.6.3.3 Italy Genomics Personalized Health Market by End User
10.2.6.4 Spain Genomics Personalized Health Market
10.2.6.4.1 Spain Genomics Personalized Health Market by Technology
10.2.6.4.2 Spain Genomics Personalized Health Market by Test Type
10.2.6.4.3 Spain Genomics Personalized Health Market by End User
10.2.6.5 United Kingdom Genomics Personalized Health Market
10.2.6.5.1 United Kingdom Genomics Personalized Health Market by Technology
10.2.6.5.2 United Kingdom Genomics Personalized Health Market by Test Type
10.2.6.5.3 United Kingdom Genomics Personalized Health Market by End User
10.2.6.6 Rest of Europe Genomics Personalized Health Market
10.2.6.6.1 Rest of Europe Genomics Personalized Health Market by Technology
10.2.6.6.2 Rest of Europe Genomics Personalized Health Market by Test Type
10.2.6.6.3 Rest of Europe Genomics Personalized Health Market by End User
10.3. ASIA-PACIFIC
10.3.1 Asia-Pacific Genomics Personalized Health Market Overview
10.3.2 Asia-Pacific Genomics Personalized Health Market Forecasts and Analysis
10.3.3 Asia-Pacific Genomics Personalized Health Market Forecasts and Analysis - By Technology
10.3.4 Asia-Pacific Genomics Personalized Health Market Forecasts and Analysis - By Test Type
10.3.5 Asia-Pacific Genomics Personalized Health Market Forecasts and Analysis - By End User
10.3.6 Asia-Pacific Genomics Personalized Health Market Forecasts and Analysis - By Countries
10.3.6.1 Australia Genomics Personalized Health Market
10.3.6.1.1 Australia Genomics Personalized Health Market by Technology
10.3.6.1.2 Australia Genomics Personalized Health Market by Test Type
10.3.6.1.3 Australia Genomics Personalized Health Market by End User
10.3.6.2 China Genomics Personalized Health Market
10.3.6.2.1 China Genomics Personalized Health Market by Technology
10.3.6.2.2 China Genomics Personalized Health Market by Test Type
10.3.6.2.3 China Genomics Personalized Health Market by End User
10.3.6.3 India Genomics Personalized Health Market
10.3.6.3.1 India Genomics Personalized Health Market by Technology
10.3.6.3.2 India Genomics Personalized Health Market by Test Type
10.3.6.3.3 India Genomics Personalized Health Market by End User
10.3.6.4 Japan Genomics Personalized Health Market
10.3.6.4.1 Japan Genomics Personalized Health Market by Technology
10.3.6.4.2 Japan Genomics Personalized Health Market by Test Type
10.3.6.4.3 Japan Genomics Personalized Health Market by End User
10.3.6.5 South Korea Genomics Personalized Health Market
10.3.6.5.1 South Korea Genomics Personalized Health Market by Technology
10.3.6.5.2 South Korea Genomics Personalized Health Market by Test Type
10.3.6.5.3 South Korea Genomics Personalized Health Market by End User
10.3.6.6 Rest of Asia-Pacific Genomics Personalized Health Market
10.3.6.6.1 Rest of Asia-Pacific Genomics Personalized Health Market by Technology
10.3.6.6.2 Rest of Asia-Pacific Genomics Personalized Health Market by Test Type
10.3.6.6.3 Rest of Asia-Pacific Genomics Personalized Health Market by End User
10.4. MIDDLE EAST AND AFRICA
10.4.1 Middle East and Africa Genomics Personalized Health Market Overview
10.4.2 Middle East and Africa Genomics Personalized Health Market Forecasts and Analysis
10.4.3 Middle East and Africa Genomics Personalized Health Market Forecasts and Analysis - By Technology
10.4.4 Middle East and Africa Genomics Personalized Health Market Forecasts and Analysis - By Test Type
10.4.5 Middle East and Africa Genomics Personalized Health Market Forecasts and Analysis - By End User
10.4.6 Middle East and Africa Genomics Personalized Health Market Forecasts and Analysis - By Countries
10.4.6.1 South Africa Genomics Personalized Health Market
10.4.6.1.1 South Africa Genomics Personalized Health Market by Technology
10.4.6.1.2 South Africa Genomics Personalized Health Market by Test Type
10.4.6.1.3 South Africa Genomics Personalized Health Market by End User
10.4.6.2 Saudi Arabia Genomics Personalized Health Market
10.4.6.2.1 Saudi Arabia Genomics Personalized Health Market by Technology
10.4.6.2.2 Saudi Arabia Genomics Personalized Health Market by Test Type
10.4.6.2.3 Saudi Arabia Genomics Personalized Health Market by End User
10.4.6.3 U.A.E Genomics Personalized Health Market
10.4.6.3.1 U.A.E Genomics Personalized Health Market by Technology
10.4.6.3.2 U.A.E Genomics Personalized Health Market by Test Type
10.4.6.3.3 U.A.E Genomics Personalized Health Market by End User
10.4.6.4 Rest of Middle East and Africa Genomics Personalized Health Market
10.4.6.4.1 Rest of Middle East and Africa Genomics Personalized Health Market by Technology
10.4.6.4.2 Rest of Middle East and Africa Genomics Personalized Health Market by Test Type
10.4.6.4.3 Rest of Middle East and Africa Genomics Personalized Health Market by End User
10.5. SOUTH AND CENTRAL AMERICA
10.5.1 South and Central America Genomics Personalized Health Market Overview
10.5.2 South and Central America Genomics Personalized Health Market Forecasts and Analysis
10.5.3 South and Central America Genomics Personalized Health Market Forecasts and Analysis - By Technology
10.5.4 South and Central America Genomics Personalized Health Market Forecasts and Analysis - By Test Type
10.5.5 South and Central America Genomics Personalized Health Market Forecasts and Analysis - By End User
10.5.6 South and Central America Genomics Personalized Health Market Forecasts and Analysis - By Countries
10.5.6.1 Brazil Genomics Personalized Health Market
10.5.6.1.1 Brazil Genomics Personalized Health Market by Technology
10.5.6.1.2 Brazil Genomics Personalized Health Market by Test Type
10.5.6.1.3 Brazil Genomics Personalized Health Market by End User
10.5.6.2 Argentina Genomics Personalized Health Market
10.5.6.2.1 Argentina Genomics Personalized Health Market by Technology
10.5.6.2.2 Argentina Genomics Personalized Health Market by Test Type
10.5.6.2.3 Argentina Genomics Personalized Health Market by End User
10.5.6.3 Rest of South and Central America Genomics Personalized Health Market
10.5.6.3.1 Rest of South and Central America Genomics Personalized Health Market by Technology
10.5.6.3.2 Rest of South and Central America Genomics Personalized Health Market by Test Type
10.5.6.3.3 Rest of South and Central America Genomics Personalized Health Market by End User

11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS

12. GENOMICS PERSONALIZED HEALTH MARKET, KEY COMPANY PROFILES
12.1. QIAGEN
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. ILLUMINA, INC.
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. THERMO FISHER SCIENTIFIC, INC.
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. BIO-RAD LABORATORIES, INC.
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. F. HOFFMANN-LA ROCHE LTD
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. INVITAE CORPORATION
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. GENETIC TECHNOLOGIES LIMITED
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. LONZA
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. INTERLEUKIN GENETICS, INC
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. DNAGENOTEK
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments

13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
The List of Companies

1. QIAGEN
2. Illumina, Inc.
3. Thermo Fisher Scientific, Inc.
4. Bio-Rad Laboratories, Inc.
5. F. Hoffmann-La Roche Ltd
6. Invitae Corporation
7. Genetic Technologies Limited
8. Lonza
9. Interleukin Genetics, Inc
10. DNAGenotek
TIPRE00007153
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing

Free

20%

customization on Pre-Booking
Request for Sample
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.